In vivo measurement of hemodialyzer fiber bundle volume: Theory and validation  by Krivitski, Nikolai M. et al.
In vivo measurement of hemodialyzer fiber bundle volume:
Theory and validation
NIKOLAI M. KRIVITSKI, VICTOR V. KISLUKHIN, JOHN W. SNYDER, DAVID R. MACGIBBON,
OLGA A. KUZNETSOVA, ADELE M. REASONS, and THOMAS A. DEPNER
Transonic Systems Inc., Ithaca, New York and University of California, Davis, California, USA
In vivo measurement of hemodialyzer fiber bundle volume: The-
ory and validation.
Background. Fiber bundle volume (FBV), the space within the
blood compartment of hollow fiber dialyzers, may decrease during
treatment due to clotting. The clots may be flushed out of the
dialyzer prior to measurements of FBV by dialyzer reprocessing
equipment and a significant drop in FBV during the session may
go unrecognized.
Methods. FBV was measured (1) from the transit time of a
saline bolus passing through the dialyzer as recorded by ultra-
sound dilution sensors placed on the arterial and venous blood
lines; (2) from the change in blood concentration induced by a
step change in the rate of ultrafiltration as recorded by the venous
sensor.
Results. In vitro FBV ranged from 47 to 121 ml. Paired absolute
differences between the ultrasound and volumetric measurements
(flushing saline out of the dialyzer into a graduated cylinder) were
0.16 6 4.23% (N 5 42) and 2.10 6 7.26% (N 5 13) for the bolus
and ultrafiltration methods, respectively. In vivo reproducibility of
the bolus and ultrafiltration methods were 2.65 6 2.11% (N 5
122) and 3.79 6 3.93% (N 5 32), respectively. During 31
treatments the FBV by dilution showed an average decrease of
4.17 6 8.60%, and in 6 cases FBV fell more than 10%, while
measurements of the same FBV by reuse equipment showed an
increase of 0.99 6 5.82%, P , 0.01.
Conclusions. FBV measured by the dilution methods was
accurate and reproducible. Preliminary results suggest that in vivo
FBV may differ significantly from results reported by reprocessing
machines.
Fiber bundle volume (FBV), the total space within the
blood compartment of hollow fiber hemodialyzers, corre-
lates closely with dialyzer surface area, a major determinant
of solute clearance. A decrease in surface area due to
clotting causes a decrease in solute clearance that puts the
patient at risk for inadequate dialysis [1, 2]. Since it
correlates with membrane surface area and is easy to
measure in vitro, in centers where reuse is permitted FBV
has been selected as the main criterion that allows a
dialyzer to be reused. The sequence of procedures for reuse
consists of cleaning, including flushing the fibers with
pressurized water to remove clots and debris, and measure-
ment of FBV by volumetric displacement of air or liquid
that is compared with the original dialyzer volume. Because
vigorous flushing removes much of the clot, FBV measured
in vitro may not represent the true in vivo volume and the
corresponding surface area available for solute exchange.
In the present study two new indicator dilution methods for
measuring FBV in vivo were developed and validated. The
indicator used was normal saline and dilution of the blood
was monitored by an ultrasound sensor attached to the
dialysis blood lines that detects concentration-dependent
changes in ultrasound velocity. A similar but converse
effect was accomplished by a step change in ultrafiltration
with ultrasound velocity monitoring. Preliminary evidence
[3, 4] from these on-line measurements of FBV suggests
that, in some patients, a significant in vivo reduction in FBV
may not be detected by in vitro volumetric measurements
performed by reuse equipment as a part of contemporary
reuse procedures.
Theoretical analysis
The indicator dilution technique for measuring FBV in
vivo employs principles that have been established for
measuring blood volume in vivo. The following conditions
must be met to allow accurate measurement of FBV using
the indicator dilution technique. (1) The injected indicator
must mix with all of the blood flowing through the system.
(2) The injected indicator must behave like other particles
within a fiber.
When flow in the system (Q) can be measured accu-
rately, the volume (V) of the system is determined by the
following equation [5]:
V 5 Q 3 MTT (Eq. 1)
where MTT (mean transit time) is the average time that the
indicator travels through the system. Two methods, one
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based on a bolus injection of normal saline and the other
based on a step change in ultrafiltration, were developed
for measuring the dialyzer FBV.
Bolus injection method
Equation 1 assumes that the time required for injection
of the indicator is negligible, that the indicator was intro-
duced just before the entrance to the dialyzer, and that a
dilution curve was recorded by the ultrasound sensor
immediately at the exit to the dialyzer. To eliminate the
influence of the injection time and the distance between the
site of injection and the dialyzer entrance, an additional
dilution sensor was placed on the blood inlet side of the
dialyzer as shown in Figure 1. To account for a finite
injection time using the two sensors, Equation 1 must be
modified. For ultrafiltration through the dialyzer turned off
(Eq. 2a) and on (Eq. 2b):
FBV 5 Qb 3 ~MTTv 2 MTTa! (Eq. 2a)
FBV 5 ~Qb 2 0.5Qf! 3 ~MTTv 2 MTTa! (Eq. 2b)
where Qb is blood flow through the dialyzer; Qf is the
ultrafiltration flow rate; MTTv and MTTa are mean transit
times of indicator recorded by the sensors placed after the
dialyzer (venous line) and before the dialyzer (arterial line)
respectively. The formulas for calculating MTT using this
bolus injection method are [4]:
MTTa 5 ECa~t! t dtYECa~t! dt (Eq. 3)
MTTv 5 ECv~t! t dtYECv~t! dt (Eq. 4)
where Ca(t) and Cv(t) are the concentration dilution curves
recorded by the arterial and venous sensors (Fig. 2).
Ultrafiltration method (step change)
The most convenient way to change blood properties
(blood density, hemoglobin concentration, hematocrit,
Fig. 1. Fiber bundle volume measurement by
ultrasound dilution (A, arterial; V, venous). For
the saline bolus technique (see Methods) both
flow-dilution sensors are used. For the
ultrafiltration method, only the venous sensor is
used.
Fig. 2. An example of the dilution curves
recorded by an arterial (pre-dialyzer)
ultrasound sensor and a venous (post-dialyzer)
sensor following an injection (10 ml) of isotonic
saline into the arterial (dialyzer inflow) blood
line.
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etc.), to allow measurement of volume, is to create a step
change in the rate of ultrafiltration. When hydrostatic
pressure is applied at the dialyzer membrane, creating a
gradient from the blood to the dialysate side, the cells and
macromolecules in the blood are concentrated by continu-
ous removal of ultrafiltrate from the entire dialyzer blood
compartment. This maneuver is analogous to simulta-
neously adding indicator to the entire dialyzer blood com-
partment. When a steady state is reached, the blood at the
entrance of the dialyzer will be less concentrated than at
the exit where it is most concentrated (Fig. 3). These
conditions differ from the traditional well developed meth-
ods for constant indicator infusion where, at steady state,
the concentration in the system is the same in all locations
[5].
The absence of an analytical formula for the relationship
between outflow concentration and FBV required develop-
ment of a theoretical model of changes in blood concen-
tration at the dialyzer blood outlet in response to a step
change in ultrafiltration (Appendix). The analysis was per-
formed in two steps. First, the outflow concentration in a
single fiber (Fig. 4) was evaluated after a step change in
ultrafiltration. The changes in a liquid flow balance and
mass balance for non-removable blood particles in the fiber
were used to develop the differential equations. Second,
the results obtained for one fiber were expanded to the
whole dialyzer with the assumption that the fractional
removal of ultrafiltrate from the blood compartment is the
same for all fibers that take part in ultrafiltration. The
fractional removal rate is Qf/FBV. Two modifications of
this formula (Equations a20 and a24 in the Appendix) were
derived for FBV when ultrafiltration occurs during dialysis
(ultrafiltration turned on):
FBV 5 Co 3 ~Qf/tana! (Eq. 5)
or:
FBV 5 ~Qb 2 Qf! 3 T (Eq. 6)
where Co is the initial concentration, before ultrafiltration
is turned on (Fig. 5), of non-diffusable substances recorded
by the venous sensor; tana and T are calculated from the
subsequent changes in concentration (Fig. 5). For the case
when ultrafiltration is turned off, see the analogous formu-
las (Equations a32 and a33 in the Appendix).
METHODS
In vitro studies
A 10 ml bolus of isotonic saline was injected into the
arterial injection port (Fig. 1) of a dialyzer circuit perfused
with citrate equine or bovine whole blood. The ultrasound
Fig. 3. Dialyzer schematic. 1 and 2 presents
the mathematical model of concentration levels
resulting from ultrafiltration pressure step
change. These changes will be added to initial
distribution of ultrafiltration rates along the
fibers (not shown in the figure). The change in
concentration from level “a” to level “b”
produces a dilution curve which is used to
measure FBV.
Fig. 4. Single fiber fluid removal model. n (x,t) is the average linear
velocity of the liquid at point x at moment t (see Appendix, Eq.a2).
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velocity dilution curves (Fig. 2) were recorded by two flow
dilution sensors (HD01; Transonic Systems Inc, USA) [6]
located 10 cm before and 10 cm after the dialyzer (Baxter
CA-110, CF-25; Fresenius F80A, F80B; Amicon Diafilter-
30). Results of the ultrafiltration step change (Qf increased
from 8 to 20 ml/min) were recorded by the venous sensor
(Fig. 5). Equations 2 and 6 were used to calculate FBV at
blood flow rates ranging from 250 to 500 ml/min and
dialysate flow rates from zero to 600 ml/min. Immediately
following the FBV measurement, the dialyzer blood com-
partment was flushed by circulating isotonic saline through
it, taking care to remove air bubbles. Flow in the blood
compartment was then stopped and while the dialysate
compartment remained filled with saline and sealed, the
saline was flushed from the blood compartment into a
graduated cylinder under air pressure. In twelve cases this
volumetric measurement of FBV was also compared to the
volumetric measurement obtained from a standard hemo-
dialyzer reuse machine (DRS-4; Fresenius Inc, Walnut
Creek, CA, USA).
In vivo studies
Fiber bundle volume in high-flux polysulfone dialyzers
(Fresenius F80A, F80B) was measured 122 times using the
bolus method and 32 times using the ultrafiltration method
(step in Qf 5 10 to 20 ml/min). Blood flow ranged from 250
to 500 ml/min. Relative change in FBV during the course of
31 treatment sessions measured by the DRS-4 and relative
change in FBV measured by the bolus dilution method
during the same 31 sessions were compared according to
the following design: (1) DRS-4 FBV values were obtained
from the reprocessing data from the reprocessing session
before each of the 31 treatments (initial measurement) and
from the reprocessing session immediately following each
of the 31 treatments (final measurement). (2) Bolus dilu-
tion method FBV values were obtained by measurement
during the first half hour of treatment (initial) and during
the last half hour of treatment (final). (3) Percent change
was calculated as: (final 2 initial)/initial 3 100.
Average relative change for each method, calculated as
Fig. 5. The upper time tracing shows dialyzer blood flow (Qb) recorded by the outflow sensor using ultrasound transit time (Methods). This pulsatile
flow falls abruptly when ultrafiltration is turned on. Coincident with starting ultrafiltration is a rise in blood concentration (density C) recorded by the
same outflow sensor using ultrasound dilution (lower tracing).
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the sum of the percent change for each session divided by
31 sessions, is reported in results. An absolute difference
between DRS-4 and dilution methods was calculated at the
beginning of the session as DRS-4 value (initial) minus
dilution value (initial) and at the end of the session as
DRS-4 value (final) minus dilution value (final).
Average absolute difference is reported in ml 6 1 SD and
is the sum of the differences divided by the number of
comparisons (N 5 62). Informed consent was obtained
from all patients.
The reproducibility of the dilution techniques was esti-
mated from two consecutive FBV measurements per-
formed within five minutes of one another. For a single pair
of measurements, the value of reproducibility was calcu-
lated as an absolute percent difference from the average
value of the two: uFBVa 2 FBV1u/FBVa 3 100% [average
value, FBVa 5 (FBV1 1 FBV2)/2]. The average value
reported is the sum of the percent differences for the pairs
divided by the number of pairs.
Data are expressed as the mean 6 1 SD. Means were
compared using Student’s t-test.
RESULTS
In vitro studies
Fiber bundle volume was in the range of 47 to 121 ml as
measured by the volumetric method. The average differ-
ence between FBV measured volumetrically with the grad-
uated cylinder (FBVv) and measured by ultrasound dilu-
tion using the bolus injection method (FBVd) (Fig. 6) was
0.16 6 4.23% (N 5 42). The reproducibility was 1.17 6
1.42% (N 5 204). FBV measured by the ultrafiltration
method underestimated the volumetric data by 15.08 6
6.04% (N 5 13). Reproducibility of the FBV measure-
ments by the ultrafiltration method was 3.06 6 2.01%, (N 5
24). The changes observed in FBV measurements while
blood flow varied from 250 to 500 ml/min and dialysate flow
varied from zero to 600 ml/min were within the range of
reproducibility.
Volumetric FBV measured using the graduated cylinder
was greater than FBV measured using the DRS-4 machine
by an average of 3.83 6 4.69%, N 5 12 (P , 0.01).
In vivo studies
Fiber bundle volume ranged from 79 to 138 ml when
measured by the bolus injection method. Reproducibility
for the bolus method was 2.65 6 2.11% (N 5 122) and for
the ultrafiltration method was 3.79 6 3.93% (N 5 32). The
percent change in FBV from the beginning to the end of 31
treatments measured by the DRS-4 machine is compared
to the percent change measured by the dilution method in
Figure 7. FBV measured by the DRS-4 machine increased
by an average of 0.99 6 5.82% during the session. The FBV
by dilution decreased by an average of 4.17 6 8.60% (P ,
0.01) during the session. The actual percent change in FBV
measured by both techniques during each of the 31 sessions
is presented in Figure 7.
An absolute comparison of FBV measured by dilution
with FBV measured by the DRS-4 machine showed that
DRS-4 measurements were less than bolus dilution method
measurements by an average of 6.62 6 11.07 ml (N 5 62).
DISCUSSION
Absolute accuracy and reproducibility
The reproducibility of both the bolus and the ultrafiltra-
tion methods was remarkable, averaging 1% to 4% for both
in vitro and in vivo FBV measurements. The bolus method
(Fig. 6) showed a good agreement with volumetric gradu-
ated cylinder method measurements (mean error 0.16 6
4.23%, N 5 42), while the ultrafiltration method signifi-
cantly underestimated FBV when measured volumetrically
by the graduated cylinder method (15% lower, P , 0.01).
These results are not unexpected as the ultrafiltration
method measures the volume that is directly involved in the
ultrafiltration process. The blood volume in the portion of
the fibers imbedded in potting material at both ends of the
dialyzer (Fig. 3) as well as the blood volume taken up by the
headers does not take part in the exchange process, and
therefore would not be a part of the ultrafiltration mea-
surements. In contrast, this volume is taken into account by
the bolus method, by the graduated cylinder method, and
by the reuse machine measurements. To account for this
difference, a simple geometrical calculation was used. First,
the volume of blood in header (Fig. 3), 8.4 ml, was taken
into consideration. Second, 11% of the total fiber length is
encased in potting material. After these factors were con-
sidered (adjusted value 5 [graduated cylinder value 2 8.4
ml] 3 0.89) the differences between the ultrafiltration
method and the graduated cylinder method were minor
(2.10 6 7.26%).
A good agreement between the ultrafiltration method
and graduated cylinder method confirms the assumption
made in the theoretical model, that fractional removal of
Fig. 6. Volumetric measurements by graduated cylinder of FBVv versus
FBVd obtained by the bolus injection method (in vitro). FBVv 5
1.04FBVd 2 4.17 ml; N 5 42. Average % difference 5 0.16 6 4.23%.
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fluid (F) under ultrafiltration pressure gradient is uniform
throughout the volume of blood in the dialyzer and in the
fibers. It should be specially pointed out that in our
equations we are not describing the distribution of ultrafil-
tration value along the fiber (Fig. 4), but a change of this
distribution under ultrafiltration pressure. The actual dis-
tribution of ultrafiltration along the fiber in addition to
applied ultrafiltration pressure is known to be a function of
ultrafiltration flow from the hydrostatic blood pressure, the
back filtration from the oncotic pressure, and the back
filtration from the hydrostatic pressure of dialysate flow [7].
When compared with volumetric measurements (gradu-
ated cylinder) and with measurements by the bolus dilution
method, FBV measured by the reuse machine was respec-
tively 4% and 5% less. This small discrepancy may be due
to an inability of the reuse machine to completely flush
saline from the fibers.
Comparison of methods
Both the bolus injection and the ultrafiltration technol-
ogies can be modified for routine clinical measurements of
FBV. Sensors may be moved closer to the patient to the
optimal position for measuring access flow and access
recirculation [6]. For the bolus method the injections into
the arterial line can be replaced by a bolus released from
the saline bag like a recently described method for access
flow measurements [8]. The ultrafiltration step change
method looks even more promising. It requires only one
(post-dialyzer) sensor, it is simpler to perform and to
automate and it appears, based on the above discussion,
that the volume measured is more pertinent to the clinical
consequence of fiber clotting causing a reduction in solute
clearance. Because the novel ultrafiltration step change and
resultant configuration of the dilution curves (Fig. 5) are
different from the traditional bolus curves (Fig. 2) more
work is required to insure the same level of quality and
robustness of the used algorithm.
Clinical relevance
The data shown in Figure 7 suggest that a significant
decrease in FBV during dialysis treatments may not be
detected by the reuse machine. One must also suspect that
in the 6 of 31 treatments where FBV measured by dilution
dropped by more than 10%, the delivered dose of dialysis
was reduced. The discrepancy between FBV measured
during dialysis by ultrasound dilution and following dialysis
by the reuse machine does not come as a surprise. The
fibrous threads that result from clotting within the hollow
fibers during dialysis are often seen during pressure rinsing
of the dialyzer after the session. The observed difference
between real FBV during dialysis and assumed FBV mea-
sured by the reuse machine may also partly explain the
results observed by different investigators who examined
the effect of dialyzer reuse on performance of the dialyzer
[9–13].
Fig. 7. Relative change of FBV during dialysis as measured by dilution and by reuse equipment.
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In future research, the relationship between FBV mea-
sured by dilution techniques and solute clearance measure-
ments should be explored in vivo.
Four possible applications in hemodialysis and hemofil-
tration for this on-line technology, including treatment for
acute renal failure are listed here:
c Early warning of ongoing clotting for conventional and
heparin free dialysis
c Quality control of dialyzer reuse
c Solute clearance control
c Optimization of heparin administration
The theoretical analysis, bench validations, and prelimi-
nary clinical data show that dialyzer fiber bundle volume
can be accurately and simply measured by indicator dilu-
tion techniques in vivo during hemodialysis and that FBV
measured by reuse equipment may not always represent the
real dialyzer blood volume during hemodialysis.
Reprint requests to Nikolai Krivitski, Ph.D., D.Sc., Transonic Systems Inc.,
34 Dutch Mill Rd., Ithaca, New York 14850, USA.
E-mail: nikolai@transonic.com
APPENDIX
The purpose of this analysis is to establish the relationship between the
outflow concentration changes Cv(t) and FBV due to ultrafiltration. The
analysis is performed in two steps. The first is an evaluation of concen-
tration changes within a single fiber. The second is an extension of the
single fiber results to the whole dialyzer. We assumed that fractional
removal of fluid (F) was uniform throughout the volume of blood in the
dialyzer and in the fibers.
F 5 Qf/FBV @ml/sec/ml 5 1/sec# (Eq. a1)
(1.) Single fiber concentration changes (Fig. 4). After ultrafiltration is
turned on, the change in concentration within a single fiber is calculated
based on liquid flow balance and nonremovable particles balance. Liquid
flow balance gives (Fig. 4):
n~x! 3 S 5 n~x 1 Dx! 3 S 1 F 3 Dx 3 S (Eq. a2)
where n(x) is the average linear velocity of liquid at point x; S is the cross
sectional area of the fiber; and F is the fractional rate of filtration in the
fiber (Eq. a1).
The second of the two terms summed in Equation a2 represents the flow
of ultrafiltrate removed from the fiber as the blood flows along the
distance Dx. Equation a2 may be rewritten in differential form:
n9~x! 5 2F (Eq. a3)
The solution of this equation is:
n~x! 5 n* 2 F 3 x (Eq. a4)
where n* is the average linear velocity of blood at the entrance to the fiber.
From a consideration of mass balance for nonremovable blood parti-
cles:
C~x,t! 3 n~x! 5 C~x 1 Dx,t 1 Dt! 3 n~x 1 Dx! (Eq. a5)
where C(x,t) is the concentration of nonremovable blood particles (red
blood cells, hemoglobins, etc.).
The relationship between Dx and Dt, as Dx and Dt 3 0, may be
expressed, as:
Dx/Dt 5 n~x! (Eq. a6)
This means that we are recording the movement of particle packet.
Decomposing the right part of Equation a5 in a Taylor series gives:
n~x 1 Dx! 5 n~x! 1 n9~x! 3 Dx (Eq. a7)
C~x 1 Dx,t 1 Dt! 5 C~x,t! 1
­C~x,t!
­x 3 Dx 1
­C~x,t!
­t 3 Dt (Eq. a8)
Combining Equations a5 to a8 with consideration of Equation a3, and
neglecting small values of the second order gives:
C~x,t! 3 F 5 C~x,t! 1
­C~x,t!
­x 3 n~x! 1
­C~x,t!
­t (Eq. a9)
Before ultrafiltration was turned on, the concentration of nondiffusable
particles was the same along the entire fiber (Eq. a10) and was equal to the
entering (initial) concentration, Co, that we may consider constant during
the measurement (Eq. a11):
C~x,0! 5 Co L $ x $ 0 (Eq. a10)
C~0,t! 5 Co (Eq. a11)
Because the concentration sensor is located at the exit of the dialyzer our
particular interest is in the outflow concentration at x 5 L (Fig. 3). The
solution of Equation a9 consists of two parts. The first part is related to the
concentration of blood that was in the fiber at the moment when
ultrafiltration was turned on. The second part is related to the blood that
enters the dialyzer after ultrafiltration was turned on and reaches location
x 5 L at time t* after passing through the entire fiber. After this moment
the process in this fiber achieves a steady state. The first part of the
solution for t , t*:
C~L,t! 5 C~L,0! 3 exp~F 3 t! 5 Co 3 exp~F 3 t! (Eq. a12)
The second part of the solution for t . t* for x 5 L:
C~L,t! 5 Co 3 1/@1 2 F 3 L/n*# (Eq. a13)
Equation a12 gives the concentration changes during the transfer process
and depends only on time “t” and F. It is also clear from Equation a12 that
the concentration will be the same for any fiber in the dialyzer at moment
“t”. Equation a13 gives the concentration during the steady state and does
not depend on time. The outflow concentration of every fiber will depend
on n*, the average linear velocity of liquid at the fiber entrance that may
be different for every fiber due to different inner diameters. Therefore, in
contrast to Equation a12 the outflow concentration at t . t* may be
different for every fiber.
(2.) Whole dialyzer concentration changes. The resulting concentration
in the dialyzer outflow, Cv(L,t), is the sum of outflow concentrations in all
fibers multiplied on their flow and divided by total flow:
Cv~L,t! 5
OCn~L,t! 3 Snn*n
OSn 3 n*n (Eq. a14)
where N 5 1 . . . n; n is the number of fibers in dialyzer; Cn(L,t) is the
outflow concentration of the “nth” fiber; Sn is the cross sectional area of
the “nth” fiber; n*n is an average line blood flow in the “nth” fiber.
It is clear from Equation a12 that the outflow concentration in Equation
a14 in every fiber at time “t” is the same until the moment when, in one
of the fibers, t . t*:
Cn~L,t! 5 Co 3 exp~F 3 t! (Eq. a15)
For dialyzer outflow:
OSn 3 n*n 5 Qb 2 Qf (Eq. a16)
Consider Equations a12, a15 and a16, and Equation a14 may be simplified
for any t , t*:
Cv~L,t! 5 Co 3 exp~F 3 t! (Eq. a17)
Equation a17 for the entire dialyzer is the same as for one fiber. This
condition exists until, in any single fiber, the blood that enters the fiber
after ultrafiltration was turned on reaches x 5 L (that is, it passes through
the entire length of the fiber). Let us estimate the practical value of
exponent F 3 t. For Qf in the range 10 to 20 ml/min, dialyzer blood
volume 60 to 120 ml, the estimation of F gives F 5 0.0014 to 0.0056/sec.
For time t in the order of 7 to 10 seconds, the value of F 3 t will be in the
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order of 0.01 to 0.05 ,, 1. Then with accuracy no less than 1% Equation
a17 may be rewritten:
Cv~L,t! 5 Co 3 ~1 1 F 3 t! 5 Co 3 ~1 1 Qf 3 t/FBV! (Eq. a18)
and the dialyzer blood volume after ultrafiltration is turned on can be
calculated from Equation a18:
FBV 5 Co 3 Qf 3 t/~Cv~L,t! 2 Co! (Eq. a19)
or
FBV 5 Co 3 Qf/tana (Eq. a20)
where tana is calculated from Figure 5.
Equation a20 can also be represented in a different form to avoid
measurement of the absolute concentration Co. The mass balance of large
particles that do not diffuse through the dialyzer at steady state may be
expressed as:
Qb 3 Ca* 5 ~Qb 2 Qf! 3 Cv* (Eq. a21)
where Ca* and Cv* are concentrations of large particles in the dialyzer
arterial and venous blood at steady state, respectively.
Before ultrafiltration is turned on, the initial concentration in the
venous line is the same as in the arterial line (Co 5 Ca). The initial venous
concentration, Co, will be the same as Ca* at steady state if Ca does not
change during transfer time Ttr. A change in Ca may occur if the
concentration change introduced by a change in ultrafiltration recirculates
through the dialyzer (FBV), through the arterial and venous tubing (Vav),
and then through the cardio-pulmonary system (Tcp) before a steady state
is reached. Ttr can be estimated based on existing tubing systems and
dialyzers:
Tr > ~Vav 1 FBV!/Qb 1 Tcp (Eq. a22)
The quickest return (worst case scenario) in the absence of access
recirculation: Vav 5 100 ml; FBV 5 60 ml; Qb 5 500 ml/min; Tcp 5 10
seconds, gives Ttr 5 30 seconds. This time is sufficiently long to allow a
steady state to be reached across the dialyzer.
For these conditions, Equation a21 may be rewritten (Ca* 5 Ca 5 Co):
Cv* 2 Co 5 Cv 3 Qf/Qb (Eq. a23)
Finally, from Equation a20, substituting tga 5 (Cv* 2 Co)/T (see Fig. 5)
and considering Equation a23, the formula for FBV when ultrafiltration is
turned on is:
FBV 5 ~Qb 2 Qf! 3 T (Eq. a24)
When these measurements were performed by turning ultrafiltration off
instead of turning it on, the initial steady state concentration along the
dialyzer will be similar to that shown in Figure 3. The equation for
concentration in a single fiber before ultrafiltration is turned off is (see Eq.
a13):
C~x,t 5 0! 5 Co 3 1/@1 2 F 3 x/n*# (Eq. a25)
where t 5 0 signifies the time at the beginning of the process, and 110 n*
is the same at any place in the fiber. The fiber outflow concentration at
time “t” depends on how far this portion is located (distance L 2 x) from
the exit. The amount of time “t” required for the portion of the blood
located at coordinate “x” to reach the fiber exit is:
t 5 ~L 2 x!/n* (Eq. a26)
The outflow concentration from Equation a25 and Equation a26 is:
C~L,t! 5 Co 3 1/@1 2 F 3 ~L 2 n* 3 t!/n* (Eq. a27)
A practical estimation of F 3 t ,, 1 was described above. The same
conditions may be applied to the expression in squared brackets of
Equation 27:
C~L,t! 5 Co 3 @1 1 F 3 ~L 2 n* 3 t!/n* (Eq. a28)
or
C~L,t! 5 Co 3 @1 1 F 3 L/n*# 2 Co 3 F 3 t (Eq. a29)
The first part of the sum is the outflow concentration in the fiber at steady
state before ultrafiltration is turned off. The resulting outflow dialyzer
concentration Cv(L,t) is the sum of outflow concentrations in all fibers
(Eq. a29) multiplied by their individual flows and divided by the total flow
(Eq. a14). The first part of the sum gives the initial level Cv*:
Cv~L,t! 5 Cn** 2 Co 3 F 3 t (Eq. a30)
or from Equation a1:
FBV 5 Co 3 Qf 3 t/~Cv** 2 Cv~L,t!! (Eq. a31)
or by analogy with Equation a20:
FBV 5 Co* 3 Qf/tanb (Eq. a32)
and also by analogy with Equation a24:
FBV 5 ~Qb 2 Qf! 3 T (Eq. a33)
The resulting formulas for FBV (Equations a20 and a32; Equations a24
and a33) are the same regardless of whether FBV is measured by turning
ultrafiltration on or by turning it off.
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